Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells.

Laskar P, Somani S, Campbell SJ, Mullin M, Keating P, Tate RJ, Irving C, Leung HY, Dufès C.

Nanoscale. 2019 Nov 14;11(42):20058-20071. doi: 10.1039/c9nr07254c. Epub 2019 Oct 15.

PMID:
31612185
2.

Exosomes: fighting cancer with cancer.

Alyamani H, Obeid MA, Tate RJ, Ferro VA.

Ther Deliv. 2019 Jan;10(1):37-61. doi: 10.4155/tde-2018-0051. Review. Erratum in: Ther Deliv. 2019 Feb;10(2):133.

PMID:
30730823
3.

Cobalt Administration Causes Reduced Contractility with Parallel Increases in TRPC6 and TRPM7 Transporter Protein Expression in Adult Rat Hearts.

Laovitthayanggoon S, Henderson CJ, McCluskey C, MacDonald M, Tate RJ, Grant MH, Currie S.

Cardiovasc Toxicol. 2019 Jun;19(3):276-286. doi: 10.1007/s12012-018-9498-3.

4.

Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells.

Laskar P, Somani S, Altwaijry N, Mullin M, Bowering D, Warzecha M, Keating P, Tate RJ, Leung HY, Dufès C.

Nanoscale. 2018 Dec 28;10(48):22830-22847. doi: 10.1039/c8nr08141g. Epub 2018 Nov 29.

PMID:
30488937
5.

Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown.

Obeid MA, Dufès C, Somani S, Mullen AB, Tate RJ, Ferro VA.

J Liposome Res. 2019 Sep;29(3):229-238. doi: 10.1080/08982104.2018.1531424. Epub 2019 Jan 1.

PMID:
30296860
6.

Native and Polyubiquitinated Forms of Dihydroceramide Desaturase Are Differentially Linked to Human Embryonic Kidney Cell Survival.

Alsanafi M, Kelly SL, Jubair K, McNaughton M, Tate RJ, Merrill AH Jr, Pyne S, Pyne NJ.

Mol Cell Biol. 2018 Nov 13;38(23). pii: e00222-18. doi: 10.1128/MCB.00222-18. Print 2018 Dec 1.

7.
8.

Disruption of the Zdhhc9 intellectual disability gene leads to behavioural abnormalities in a mouse model.

Kouskou M, Thomson DM, Brett RR, Wheeler L, Tate RJ, Pratt JA, Chamberlain LH.

Exp Neurol. 2018 Oct;308:35-46. doi: 10.1016/j.expneurol.2018.06.014. Epub 2018 Jun 23.

9.

Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12.

Altwaijry N, Somani S, Parkinson JA, Tate RJ, Keating P, Warzecha M, Mackenzie GR, Leung HY, Dufès C.

Drug Deliv. 2018 Nov;25(1):679-689. doi: 10.1080/10717544.2018.1440666.

10.

Formulation of Nonionic Surfactant Vesicles (NISV) Prepared by Microfluidics for Therapeutic Delivery of siRNA into Cancer Cells.

Obeid MA, Elburi A, Young LC, Mullen AB, Tate RJ, Ferro VA.

Mol Pharm. 2017 Jul 3;14(7):2450-2458. doi: 10.1021/acs.molpharmaceut.7b00352. Epub 2017 Jun 8.

11.

Transcutaneous spinal direct current stimulation induces lasting fatigue resistance and enhances explosive vertical jump performance.

Berry HR, Tate RJ, Conway BA.

PLoS One. 2017 Apr 5;12(4):e0173846. doi: 10.1371/journal.pone.0173846. eCollection 2017.

12.

Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles (NISV) prepared using different manufacturing methods.

Obeid MA, Gebril AM, Tate RJ, Mullen AB, Ferro VA.

Int J Pharm. 2017 Apr 15;521(1-2):54-60. doi: 10.1016/j.ijpharm.2017.02.007. Epub 2017 Feb 3.

13.

The effects of hydration media on the characteristics of non-ionic surfactant vesicles (NISV) prepared by microfluidics.

Obeid MA, Khadra I, Mullen AB, Tate RJ, Ferro VA.

Int J Pharm. 2017 Jan 10;516(1-2):52-60. doi: 10.1016/j.ijpharm.2016.11.015. Epub 2016 Nov 9.

14.

Determination of the potential bioavailability of plant microRNAs using a simulated human digestion process.

Philip A, Ferro VA, Tate RJ.

Mol Nutr Food Res. 2015 Oct;59(10):1962-72. doi: 10.1002/mnfr.201500137. Epub 2015 Aug 12.

15.

Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes.

Lim LY, Koh PY, Somani S, Al Robaian M, Karim R, Yean YL, Mitchell J, Tate RJ, Edrada-Ebel R, Blatchford DR, Mullin M, Dufès C.

Nanomedicine. 2015 Aug;11(6):1445-54. doi: 10.1016/j.nano.2015.04.006. Epub 2015 Apr 29.

16.

Toxicity of cobalt-chromium nanoparticles released from a resurfacing hip implant and cobalt ions on primary human lymphocytes in vitro.

Posada OM, Tate RJ, Grant MH.

J Appl Toxicol. 2015 Jun;35(6):614-22. doi: 10.1002/jat.3100. Epub 2015 Jan 21.

17.

Effects of CoCr metal wear debris generated from metal-on-metal hip implants and Co ions on human monocyte-like U937 cells.

Posada OM, Tate RJ, Grant MH.

Toxicol In Vitro. 2015 Mar;29(2):271-80. doi: 10.1016/j.tiv.2014.11.006. Epub 2014 Nov 27.

18.

CoCr wear particles generated from CoCr alloy metal-on-metal hip replacements, and cobalt ions stimulate apoptosis and expression of general toxicology-related genes in monocyte-like U937 cells.

Posada OM, Gilmour D, Tate RJ, Grant MH.

Toxicol Appl Pharmacol. 2014 Nov 15;281(1):125-35. doi: 10.1016/j.taap.2014.09.010. Epub 2014 Oct 2.

19.

The p.Arg86Gln change in GARP2 (glutamic acid-rich protein-2) is a common West African-related polymorphism.

Gibriel AA, Tate RJ, Yu Y, Rawson-Lax E, Hammer HM, Tettey JN, Pyne NJ, Converse CA.

Gene. 2013 Feb 15;515(1):155-8. doi: 10.1016/j.gene.2012.11.005. Epub 2012 Nov 30.

PMID:
23201897
20.

The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism.

Tonelli F, Alossaimi M, Williamson L, Tate RJ, Watson DG, Chan E, Bittman R, Pyne NJ, Pyne S.

Br J Pharmacol. 2013 Mar;168(6):1497-505. doi: 10.1111/bph.12035.

21.

Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system.

Lemarié F, Croft DR, Tate RJ, Ryan KM, Dufès C.

Biomaterials. 2012 Mar;33(9):2701-9. doi: 10.1016/j.biomaterials.2011.12.019. Epub 2011 Dec 24.

PMID:
22200536
22.

Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex.

Aldawsari H, Edrada-Ebel R, Blatchford DR, Tate RJ, Tetley L, Dufès C.

Biomaterials. 2011 Sep;32(25):5889-99. doi: 10.1016/j.biomaterials.2011.04.079. Epub 2011 May 18.

PMID:
21596431
23.

Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex.

Aldawsari H, Raj BS, Edrada-Ebel R, Blatchford DR, Tate RJ, Tetley L, Dufès C.

Nanomedicine. 2011 Oct;7(5):615-23. doi: 10.1016/j.nano.2011.01.016. Epub 2011 Feb 17.

PMID:
21333755
24.

The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.

Loveridge C, Tonelli F, Leclercq T, Lim KG, Long JS, Berdyshev E, Tate RJ, Natarajan V, Pitson SM, Pyne NJ, Pyne S.

J Biol Chem. 2010 Dec 10;285(50):38841-52. doi: 10.1074/jbc.M110.127993. Epub 2010 Oct 6.

25.

Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA.

Koppu S, Oh YJ, Edrada-Ebel R, Blatchford DR, Tetley L, Tate RJ, Dufès C.

J Control Release. 2010 Apr 19;143(2):215-21. doi: 10.1016/j.jconrel.2009.11.015. Epub 2009 Nov 26.

PMID:
19944722
26.

Side-on binding of p-sulphonatocalix[4]arene to the dinuclear platinum complex trans-[{PtCl(NH3)2}2mu-dpzm]2+ and its implications for anticancer drug delivery.

Wheate NJ, Abbott GM, Tate RJ, Clements CJ, Edrada-Ebel R, Johnston BF.

J Inorg Biochem. 2009 Mar;103(3):448-54. doi: 10.1016/j.jinorgbio.2008.12.011. Epub 2008 Dec 27.

PMID:
19171382
27.

Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice.

Mooney MH, Fogarty S, Stevenson C, Gallagher AM, Palit P, Hawley SA, Hardie DG, Coxon GD, Waigh RD, Tate RJ, Harvey AL, Furman BL.

Br J Pharmacol. 2008 Apr;153(8):1669-77. doi: 10.1038/bjp.2008.37. Epub 2008 Feb 25.

28.
29.

Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells.

Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FE.

Circ Res. 2003 Nov 14;93(10):957-64. Epub 2003 Oct 9.

PMID:
14551239
30.

Properties of the cellular prion protein expressed in Xenopus oocytes.

Connolly JG, Tate RJ, McLennan NF, Brown D, Telling GC, Fraser J, Head MW.

Neuroreport. 2002 Jul 2;13(9):1229-33.

PMID:
12151775
31.
32.

Management of severe postnasal haemorrhage: the Kingsley splint revisited.

Sherman JA, Tate RJ.

Br J Oral Maxillofac Surg. 2000 Aug;38(4):264-6.

PMID:
10922147
33.

Potential role for kv3.1b channels as oxygen sensors.

Osipenko ON, Tate RJ, Gurney AM.

Circ Res. 2000 Mar 17;86(5):534-40.

PMID:
10720415
34.
35.

The gamma-subunit of the rod photoreceptor cGMP-binding cGMP-specific PDE is expressed in mouse lung.

Tate RJ, Lochhead A, Brzeski H, Arshavsky V, Pyne NJ.

Cell Biochem Biophys. 1998;29(1-2):133-44.

PMID:
9631242
36.

Trypsin stimulates proteinase-activated receptor-2-dependent and -independent activation of mitogen-activated protein kinases.

Belham CM, Tate RJ, Scott PH, Pemberton AD, Miller HR, Wadsworth RM, Gould GW, Plevin R.

Biochem J. 1996 Dec 15;320 ( Pt 3):939-46.

37.

Mandibular deformity associated with Paget's disease. Case report.

Thomas DW, Tate RJ, Shepherd JP.

Aust Dent J. 1994 Jun;39(3):162-4. Review.

PMID:
8067932
38.

Non-Hodgkin's lymphoma presenting at the site of a recent dental extraction: a report of two cases.

Thomas DW, Gray W, Tate RJ.

Br J Oral Maxillofac Surg. 1991 Feb;29(1):34-7.

PMID:
2004074
39.

Unusual facial abscess. Report of a case.

Tate RJ.

Br Dent J. 1971 Dec 7;131(11):504. No abstract available.

PMID:
5291409
40.

Facial injuries associated with the battered child syndrome.

Tate RJ.

Br J Oral Surg. 1971 Jul;9(1):41-5. No abstract available.

PMID:
5315395
41.

Emergencies in the dental surgery.

Tate RJ.

Apex. 1970 Spring;4(2):11-5. No abstract available.

PMID:
5270693

Supplemental Content

Support Center